 |
 |
 |
 |
 |
 |
 |
 |
 |
The First Man to Be Cured of HIV: An Update on the Fascinating Story
An interview with Jeffrey Laurence, M.D.
An Evaluation of Routine HIV Testing and Its Impact on HAART InitiationCME/CE CENTRAL
Free credit for U.S. physicians, nurses and pharmacists!
Increased Presence, Severity of Coronary Artery Plaques in HIV-Infected Men
Canada: Fewer HIV Patients Becoming Drug-Resistant -- B.C. Study
California: San Francisco Hep C Task Force Launched
Feb. 16-19, 2010
San Francisco, Calif.
17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
March 8-11, 2010
Atlanta, Ga.
2010 National STD Prevention Conference
March 17-19, 2010
Sorrento, Italy
8th European HIV Drug Resistance Workshop: From Basic Science to Clinical Decision Making
Clinical Management of the HIV-Infected Woman
A Podcast Discussion With Kimberly Smith, M.D., M.P.H., and Valerie Stone, M.D., M.P.H.
New Paradigms of First-Line HIV Therapy: Determining When (and With What) to Start
A Podcast Discussion With Eric Daar, M.D., and Trevor Hawkins, M.D.
HIV Frontlines -- U.S. Edition
An Interview With Dr. Debbie Hagins, Clinical Director of a Ryan White Clinic in Georgia
Bone Disease and HIV/AIDS: More Common Than You Think
An Interview With Todd Brown, M.D., Ph.D., and Ben Young, M.D., Ph.D.
Can a Trofile Assay Be Used to Predict HIV Disease Progression?
An Interview With Matthew Goetz, M.D.
Innovative Widget Provides N.Y. Emergency Rooms With PEP Info
An Interview With Antonio Urbina, M.D.
Virologic Suppression Is Less Likely Among Antiretroviral-Experienced Black Women. But Why?
A Discussion With Kimberly Smith, M.D., M.P.H.
Which IAS 2009 Studies Are Most Likely to Impact Clinical Care?
A Discussion With Joel Gallant, M.D., M.P.H.
During First 45 Days Post HAART Initiation Patients Hospitalized Most Often for Non-AIDS-Defining Infections
An Interview With Stephen Berry, M.D.
HPV, Anal Cancer and Cervical Cancer: An Update on Pathogenesis, Treatment and Prevention
An Interview With Joel Palefsky, M.D.
